Cell line | Treatment | % subG1 | % G1 | % G2/M | % S |
---|---|---|---|---|---|
ML1 (FTC) | Untreated | 0.39 ± 0.1 | 37.5 ± 2.1 | 30.5 ± 2.4 | 32.0 ± 2.2 |
24 h ABT-737 | 21.2 ± 2.9* | 34.0 ± 3.1 | 21.5 ± 1.9* | 44.5 ± 3.6* | |
FTC236 (FTC) | Untreated | 0.21 ± 0.1 | 48.5 ± 4.4 | 24.1 ± 1.6 | 27.4 ± 2.0 |
24 h ABT-737 | 18.8 ± 2.0* | 41.6 ± 3.9 | 20.3 ± 2.6 | 38.1 ± 2.9* | |
BHT101 (PTC) | Untreated | 3.16 ± 2.8 | 65.1 ± 5.3 | 16.0 ± 1.7 | 18.9 ± 2.3 |
24 h ABT-737 | 54.8 ± 4.6* | 42.6 ± 5.3* | 16.1 ± 2.7 | 41.3 ± 5.0* | |
SW1736 (ATC) | Untreated | 1.52 ± 0.4 | 54.9 ± 5.4 | 15.2 ± 2.2 | 29.9 ± 2.6 |
24 h ABT-737 | 39.9 ± 5.9* | 42.8 ± 4.5* | 13.2 ± 1.2 | 44.0 ± 3.6* | |
HTh7 (ATC) | Untreated | 3.10 ± 0.2 | 60.1 ± 4.9 | 10.6 ± 0.8 | 29.3 ± 2.6 |
24 h ABT-737 | 11.1 ± 1.4* | 59.6 ± 4.7 | 3.3 ± 0.4* | 37.1 ± 2.6* |